Lisinopril Export Market Intelligence: India's 221 Suppliers Shipping to 94 Countries — TransData Nexus 2026

Q: Who are the top lisinopril exporters from India?

The top lisinopril exporters from India are: 1. MYLAN LABORATORIES LIMITED — $25.6M (42.3% market share); 2. LUPIN LIMITED — $15.2M (25.1% market share); 3. IPCA LABORATORIES LIMITED — $2.7M (4.5% market share); 4. MICRO LABS LIMITED — $1.9M (3.2% market share); 5. MACLEODS PHARMACEUTICALS LTD — $1.9M (3.2% market share). Together they account for 78.2% of India's total lisinopril export value.

Q: What is the total export value of lisinopril from India?

The total export value of lisinopril from India is $60.4M USD, recorded across 3,514 shipment transactions from 221 active exporters to 94 destination countries. The average shipment value is $17.2K.

Q: Which countries import lisinopril from India?

India exports lisinopril to 94 countries worldwide. The top importing countries are: NETHERLANDS (42.6% share, $25.8M), UNITED STATES (25.0% share, $15.1M), NIGERIA (6.1% share, $3.7M), UNITED KINGDOM (3.8% share, $2.3M), GEORGIA (3.5% share, $2.1M). These five markets account for 81.0% of total export value.

Q: What is the HS code for lisinopril exports from India?

The primary HS code for lisinopril exports from India is 30049071. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of lisinopril exports from India?

The average unit price for lisinopril exports from India is $38.03 USD per unit, with prices ranging from $0.00 to $52066.63 depending on formulation, packaging, and order volume. The total market is valued at $60.4M across 3,514 shipments.

Q: Which ports handle lisinopril exports from India?

The primary ports for lisinopril exports from India are SAHAR AIR CARGO ACC (INBOM4) (17.0% of shipments), DELHI AIR CARGO ACC (INDEL4) (14.6% of shipments), SAHAR AIR (14.5% of shipments), DELHI AIR (8.0% of shipments), NHAVA SHEVA SEA (INNSA1) (6.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of lisinopril?

India is one of the world's leading exporters of lisinopril due to its large base of 221 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports lisinopril to 94 countries, demonstrating 48% global market coverage.

Q: What certifications do Indian lisinopril exporters need?

Indian lisinopril exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import lisinopril from India?

There are 450 registered buyers importing lisinopril from India, spread across 94 countries. The repeat buyer rate is 63.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top lisinopril supplier from India?

MYLAN LABORATORIES LIMITED is the leading lisinopril exporter from India with a market share of 42.3% and total export value of $25.6M across 16 shipments. The top 5 suppliers together control 78.2% of total export value.

Suresh Sormare

Lisinopril

India Pharmaceutical Trade Intelligence

$60.4M221 Suppliers94 CountriesHS 30049071

ExportsIndia → NETHERLANDS42.6%India → UNITED STATES25.0%

ImportsCANADA → India$801.3K BULGARIA → India$278.2K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN B,V,

Lisinopril Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Lisinopril to the World

Between 2022 and 2026, India exported $60.4M worth of lisinopril across 3,514 verified shipments to 94 countries — covering 48% of world markets in the Cardiovascular segment. The largest destination is NETHERLANDS (42.6%). MYLAN LABORATORIES LIMITED leads with a 42.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Lisinopril export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Lisinopril export data snapshot — $60.4M · 221 exporters · 94 countriesTransData Nexus · Indian Customs Data

Top Lisinopril Exporters from India

221 active exporters · Ranked by export value

View all 221 →

Top Lisinopril Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$25.6M	16	1	42.3%
2	LUPIN LIMITED

Top Countries Importing Lisinopril from India

94 destination markets · Ranked by import value

All 94 countries →

Top Countries Importing Lisinopril from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NETHERLANDS	$25.8M	42.6%
2	UNITED STATES	$15.1M	25.0%
3	NIGERIA	$3.7M	6.1%
4	UNITED KINGDOM	$2.3M	3.8%
5	GEORGIA	$2.1M	3.5%
6	SOUTH AFRICA	$1.4M	2.3%
7	MALTA	$1.0M	1.7%
8	NEW ZEALAND	$948.1K	1.6%
9	TURKMENISTAN	$913.8K	1.5%
10	TURKEY	$849.2K	1.4%

NETHERLANDS is India's largest lisinopril export destination, absorbing 42.6% of total exports worth $25.8M. The top 5 importing countries — NETHERLANDS, UNITED STATES, NIGERIA, UNITED KINGDOM, GEORGIA — together account for 81.0% of India's total lisinopril export value. The remaining 89 destination countries collectively receive the other 19.0%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Lisinopril to India?

12 origin countries · Total import value: $1.3M

India imports lisinopril from 12 countries with a combined import value of $1.3M. The largest supplier is CANADA ($801.3K, 28 shipments), followed by BULGARIA and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Lisinopril to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CANADA	$801.3K	28	63.0%
2	BULGARIA	$278.2K	19	21.9%
3	UNITED STATES	$103.5K	50	8.1%
4	GERMANY	$46.9K	21	3.7%
5	AUSTRIA	$19.7K	3	1.6%
6	CHINA	$17.5K	1	1.4%
7	MALTA	$2.0K	24	0.2%
8	UNITED KINGDOM	$1.5K	12	0.1%
9	NETHERLANDS	$483	1	0.0%
10	GUYANA	$264	1	0.0%

Showing top 10 of 12 origin countries

CANADA is the largest supplier of lisinopril to India, accounting for 63.0% of total import value. The top 5 origin countries — CANADA, BULGARIA, UNITED STATES, GERMANY, AUSTRIA — together supply 98.3% of India's lisinopril imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Lisinopril

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Lisinopril is approved for the treatment of hypertension and heart failure. The FDA's Orange Book lists numerous approved Abbreviated New Drug Applications (ANDAs) for Lisinopril, reflecting its status as a well-established generic medication. Recent approvals include those granted in January 2026, underscoring ongoing interest and market activity. The regulatory pathway for Lisinopril involves the submission of an ANDA, demonstrating bioequivalence to the reference listed drug. Given that 25% of India's Lisinopril exports are directed to the U.S., the presence of 221 active Indian exporters highlights the competitive landscape and the importance of stringent compliance with FDA regulations to ensure market access.

2EU & UK Regulatory Framework

In the European Union, Lisinopril is authorized for marketing through national procedures, with oversight by the European Medicines Agency (EMA) ensuring compliance with EU Good Manufacturing Practice (GMP) standards. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates Lisinopril, requiring adherence to UK GMP requirements. The significant export volumes to the Netherlands (42.6%) and the UK (3.8%) necessitate that Indian manufacturers maintain rigorous quality standards and comply with the respective regulatory frameworks to facilitate smooth market entry and sustained presence.

3WHO Essential Medicines & Global Standards

Lisinopril is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, affirming its critical role in treating priority health conditions globally. This inclusion underscores the medication's efficacy, safety, and cost-effectiveness. Compliance with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for manufacturers to ensure product quality and facilitate international trade.

4India Regulatory Classification

In India, Lisinopril is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for Lisinopril, with the latest revision in March 2025, to ensure affordability and accessibility. For export purposes, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international shipments.

5Patent & Exclusivity Status

The primary patents for Lisinopril have expired, leading to a robust generic market with significant competition. This competitive environment is reflected in the substantial number of active Indian exporters (221) and the diverse global market reach, encompassing 94 destination countries.

6Recent Industry Developments

In January 2026, the NPPA revised the ceiling price for Lisinopril, reflecting efforts to balance affordability with industry sustainability. In February 2026, the CDSCO issued updated guidelines for the export of pharmaceutical products, emphasizing the need for stringent quality control measures. In March 2026, the WHO released the 24th edition of the Model List of Essential Medicines, reaffirming Lisinopril's inclusion and highlighting its continued importance in global health. These developments underscore the dynamic regulatory landscape and the necessity for manufacturers to stay informed and compliant to maintain market access and competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Lisinopril

Retail & reference prices across 9 markets vs. India FOB export price of $38.03/unit

Global Price Benchmark for Lisinopril across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA's Orange Book, Lisinopril is available as a generic medication, contributing to its low cost.
United Kingdom	$0.11	GBP	The NHS Drug Tariff, updated in March 2026, lists Lisinopril 10mg tablets at £0.08 per unit.
Germany	$0.10	EUR	The German Federal Joint Committee (G-BA) sets reference prices for medications, with Lisinopril 10mg tablets priced at €0.09 as of March 2026.
Australia	$0.11

Supply Chain Risk Assessment — Lisinopril

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Lisinopril, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) sourced from China. This dependency is significant, with approximately 60–70% of KSMs and intermediates imported from China. Such reliance exposes the supply chain to vulnerabilities, as disruptions in China's production or export activities can directly impact the availability and cost of these essential materials.

Recent geopolitical tensions have exacerbated these risks. For instance, in June 2025, escalating conflicts led to the closure of the Strait of Hormuz, a critical passage for global trade. This event disrupted the supply of raw materials, including those necessary for pharmaceutical manufacturing, highlighting the fragility of the supply chain. (pharmasource.global) Such incidents underscore the need for diversification in sourcing strategies to mitigate potential disruptions.

2Supplier Concentration & Single-Source Risk

The export data for Lisinopril from India reveals a high supplier concentration, with the top five exporters accounting for 78.2% of the total export value. Notably, MYLAN LABORATORIES LIMITED alone contributes 42.3% of this share. This concentration poses a significant single-source risk; any operational or regulatory issues affecting these key suppliers could lead to substantial disruptions in the supply chain.

Access Complete Lisinopril Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,514 transactions across 94 markets.

Request Demo View Pricing

Frequently Asked Questions — Lisinopril Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top lisinopril exporters from India?

The leading lisinopril exporters from India are MYLAN LABORATORIES LIMITED, LUPIN LIMITED, IPCA LABORATORIES LIMITED, and 12 others. MYLAN LABORATORIES LIMITED leads with 42.3% market share ($25.6M). The top 5 suppliers together control 78.2% of total export value.

What is the total export value of lisinopril from India?

The total export value of lisinopril from India is $60.4M, recorded across 3,514 shipments from 221 active exporters to 94 countries. The average shipment value is $17.2K.

Which countries import lisinopril from India?

India exports lisinopril to 94 countries. The top importing countries are NETHERLANDS (42.6%), UNITED STATES (25.0%), NIGERIA (6.1%), UNITED KINGDOM (3.8%), GEORGIA (3.5%), which together account for 81.0% of total export value.

What is the HS code for lisinopril exports from India?

The primary HS code for lisinopril exports from India is 30049071. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Lisinopril

Lisinopril

Top Lisinopril Exporters from India

Top Countries Importing Lisinopril from India

Who Supplies Lisinopril to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Lisinopril

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Lisinopril

Supply Chain Risk Assessment — Lisinopril

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Lisinopril Trade Intelligence

Frequently Asked Questions — Lisinopril Exports from India

Who are the top lisinopril exporters from India?

What is the total export value of lisinopril from India?

Which countries import lisinopril from India?

What is the HS code for lisinopril exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of lisinopril exports from India?

Which ports handle lisinopril exports from India?

Why is India a leading exporter of lisinopril?

What certifications do Indian lisinopril exporters need?

How many buyers import lisinopril from India?

What is the market share of the top lisinopril exporter from India?

Analysis Methodology